Literature DB >> 1324071

(S)-homoquisqualate: a potent agonist at the glutamate metabotropic receptor.

R H Porter1, P J Roberts, D E Jane, J C Watkins.   

Abstract

The synthetic quisqualate analogue, (S)-homoquisqualate was examined for activity at the glutamate metabotropic receptor, in relation to its ability to stimulate phosphoinositide hydrolysis in rat pup cerebro-cortical slices. The compound produced a robust increase in hydrolysis (EC50 = 50.2 +/- 1.6 microM), which, in common with responses to quisqualate and (1S,3R)-1-aminocyclopentane-1,3-dicarboxylate ((1S,3R)-ACPD), was antagonized uncompetitively by L-2-amino-3-phosphonopropionate (L-AP3). In contrast to quisqualate which exhibits low efficacy, (S)-homoquisqualate behaves as a full agonist at the metabotropic receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324071      PMCID: PMC1907545          DOI: 10.1111/j.1476-5381.1992.tb14366.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Inhibition of excitatory amino acid-stimulated phosphoinositide hydrolysis in rat hippocampus by L-aspartate-beta-hydroxamate.

Authors:  G C Ormandy
Journal:  Brain Res       Date:  1992-02-14       Impact factor: 3.252

2.  (2S,3S,4S) alpha-(carboxycyclopropyl)glycine is a novel agonist of metabotropic glutamate receptors.

Authors:  Y Nakagawa; K Saitoh; T Ishihara; M Ishida; H Shinozaki
Journal:  Eur J Pharmacol       Date:  1990-08-02       Impact factor: 4.432

Review 3.  Pharmacological and functional characteristics of metabotropic excitatory amino acid receptors.

Authors:  D Schoepp; J Bockaert; F Sladeczek
Journal:  Trends Pharmacol Sci       Date:  1990-12       Impact factor: 14.819

4.  Trans-ACPD, a selective agonist of the phosphoinositide-coupled excitatory amino acid receptor.

Authors:  E Palmer; D T Monaghan; C W Cotman
Journal:  Eur J Pharmacol       Date:  1989-08-03       Impact factor: 4.432

5.  The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells.

Authors:  F Nicoletti; J T Wroblewski; A Novelli; H Alho; A Guidotti; E Costa
Journal:  J Neurosci       Date:  1986-07       Impact factor: 6.167

6.  Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid.

Authors:  D D Schoepp; B G Johnson; E C Smith; L A McQuaid
Journal:  Mol Pharmacol       Date:  1990-08       Impact factor: 4.436

7.  Possible heterogeneity of metabotropic glutamate receptors induced in Xenopus oocytes by rat brain mRNA.

Authors:  S Tanabe; I Ito; H Sugiyama
Journal:  Neurosci Res       Date:  1991-02       Impact factor: 3.304

8.  A family of metabotropic glutamate receptors.

Authors:  Y Tanabe; M Masu; T Ishii; R Shigemoto; S Nakanishi
Journal:  Neuron       Date:  1992-01       Impact factor: 17.173

  8 in total
  4 in total

Review 1.  Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias.

Authors:  K Sengmany; K J Gregory
Journal:  Br J Pharmacol       Date:  2015-11-11       Impact factor: 8.739

2.  The effects of (RS)-alpha-cyclopropyl-4-phosphonophenylglycine ((RS)-CPPG), a potent and selective metabotropic glutamate receptor antagonist.

Authors:  N J Toms; D E Jane; M C Kemp; J S Bedingfield; P J Roberts
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord.

Authors:  M Ishida; T Saitoh; K Shimamoto; Y Ohfune; H Shinozaki
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

4.  Characterization of metabotropic glutamate receptor-stimulated phosphoinositide hydrolysis in rat cultured cerebellar granule cells.

Authors:  N J Toms; D E Jane; H W Tse; P J Roberts
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.